|
1
|
Bermúdez-Morales VH, Peralta-Zaragoza O,
Alcocer-González JM, Moreno J and Madrid-Marina V: IL-10 expression
is regulated by HPV E2 protein in cervical cancer cells. Mol Med
Rep. 4:369–375. 2011.PubMed/NCBI
|
|
2
|
Heiskanen M, Kähönen M, Hurme M, Lehtimäki
T, Mononen N, Juonala M, Hutri-Kähönen N, Viikari J, Raitakari O
and Hulkkonen J: Polymorphism in the IL10 promoter region and early
markers of atherosclerosis: the Cardiovascular Risk in Young Finns
Study. Atherosclerosis. 208:190–6. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kim J, Cho YA, Choi IJ, Lee YS, Kim SY,
Shin A, Cho SJ, Kook MC, Nam JH, Ryu KW, et al: Effects of
interleukin-10 polymorphisms, Helicobacter pylori infection,
and smoking on the risk of noncardia gastric cancer. PLoS One.
7:e296432012.PubMed/NCBI
|
|
4
|
Strey CW, Marquez-Pinilla RM, Markiewski
MM, Siegmund B, Oppermann E, Lambris JD and Bechstein WO: Early
post-operative measurement of cytokine plasma levels combined with
pre-operative bilirubin levels identify high-risk patients after
liver resection. Int J Mol Med. 27:447–454. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamimoto M, Mizuno S and Nakamura T:
Reciprocal regulation of IL-6 and IL-10 balance by HGF via
recruitment of heme oxygenase-1 in macrophages for attenuation of
liver injury in a mouse model of endotoxemia. Int J Mol Med.
24:161–170. 2009.PubMed/NCBI
|
|
6
|
Lowe PR, Galley HF, Abdel-Fattah A and
Webster NR: Influence of interleukin-10 polymorphisms on
interleukin-10 expression and survival in critically ill patients.
Crit Care Med. 31:34–38. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mazighi M, Pellé A, Gonzalez W, Mtairag el
M, Philippe M, Hénin D, Michel JB and Feldman LJ: IL-10 inhibits
vascular smooth muscle cell activation in vitro and in vivo. Am J
Physiol Heart Circ Physiol. 287:H866–71. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Suárez A, Castro P, Alonso R, Mozo L and
Gutiérrez C: Interindividual variations in constitutive
interleukin-10 messenger RNA and protein levels and their
association with genetic polymorphisms. Transplantation.
75:711–717. 2003.PubMed/NCBI
|
|
9
|
Di Bona D, Rizzo C, Bonaventura G, Candore
G and Caruso C: Association between interleukin-10 polymorphisms
and Alzheimer’s disease: a systematic review and meta-analysis. J
Alzheimers Dis. 12:751–759. 2012.
|
|
10
|
Liu F, Li B, Wang WT, Wei YG, Yan LN, Wen
TF, Xu MQ and Yang JY: Interleukin-10-1082G/A polymorphism and
acute liver graft rejection: a meta-analysis. World J
Gastroenterol. 18:847–854. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv C, Wang Y, Wang J, Zhang H, Xu H and
Zhang D: Association of Interleukin-10 gene polymorphisms with
ankylosing spondylitis. Clin Invest Med. 34:E3702011.PubMed/NCBI
|
|
12
|
Munshi A, Rajeshwar K, Kaul S, Al-Hazzani
A, Alshatwi AA, Sai Babu M, Usha A and Jyothy A:
Interleukin-10-1082 promoter polymorphism and ischemic stroke risk
in a South Indian population. Cytokine. 52:221–224. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Peng WJ, Wang BX, Pan HF, Tao JH, Zhang
JQ, He Q, Xiao CC and Wang J: Association of the interleukin-10
1082G/A, 819C/T and 3575T/A gene polymorphisms with systemic
sclerosis: a meta-analysis. Mol Biol Rep. 39:6851–6855. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saxena M, Agrawal CG, Bid HK and Banerjee
M: An Interleukin-10 Gene Promoter Polymorphism (-592A/C)
Associated with Type 2 Diabetes: A North Indian Study. Biochem
Genet. Feb 2–2012.(Epub ahead of print).
|
|
15
|
Schuurhof A, Janssen R, de Groot H,
Hodemaekers HM, de Klerk A, Kimpen JL and Bont L: Local
interleukin-10 production during respiratory syncytial virus
bronchiolitis is associated with post-bronchiolitis wheeze. Respir
Res. 12:1212011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tanabe S and Hochi S: Oral administration
of a galactooligosaccharide preparation inhibits development of
atopic dermatitis-like skin lesions in NC/Nga mice. Int J Mol Med.
25:331–336. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Y, Zheng J, Liu P, Yu X, Zhou D,
Jiang L, You Y and Zhou Y: Association between the Interleukin
10-1082G>A polymorphism and coronary heart disease risk in a
Caucasian population: a meta-analysis. Int J Immunogenet.
39:144–150. 2012.
|
|
18
|
Zhang J, Zhang Y, Jin J, Li M, Xie K, Wen
C, Cheng R, Chen C and Lu J: The -1082A/G polymorphism in the
Interleukin-10 gene and the risk of rheumatoid arthritis: a
meta-analysis. Cytokine. 56:351–355. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Reuss E, Fimmers R, Kruger A, Becker C,
Rittner C and Höhler T: Differential regulation of interleukin-10
production by genetic and environmental factors--a twin study.
Genes Immun. 3:407–413. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Westendorp RG, Langermans JA, Huizinga TW,
Elouali AH, Verweij CL, Boomsma DI and Vandenbroucke JP: Genetic
influence on cytokine production and fatal meningococcal disease.
Lancet. 349:170–173. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Turner DM, Williams DM, Sankaran D,
Lazarus M, Sinnott PJ and Hutchinson IV: An investigation of
polymorphism in the interleukin-10 gene promoter. Eur J
Immunogenet. 24:1–8. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Galley HF, Lowe PR, Carmichael RL and
Webster NR: Genotype and interleukin-10 responses after
cardiopulmonary bypass. Br J Anaesth. 91:424–6. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Karhukorpi J, Laitinen T, Karttunen R and
Tiilikainen AS: The functionally important IL-10 promoter
polymorphism (-1082G-->A) is not a major genetic regulator in
recurrent spontaneous abortions. Mol Hum Reprod. 7:201–203. 2001.
View Article : Google Scholar
|
|
24
|
Arosio B, Mastronardi L, Vergani C and
Annoni G: Interleukin-10 promoter polymorphism in mild cognitive
impairment and in its clinical evolution. Int J Alzheimers Dis.
20:8545272010.PubMed/NCBI
|
|
25
|
López-Maderuelo D, Arnalich F, Serantes R,
González A, Codoceo R, Madero R, Vázquez JJ and Montiel C:
Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary
tuberculosis. Am J Respir Crit Care Med. 167:970–975.
2003.PubMed/NCBI
|
|
26
|
Baier RJ, Loggins J and Yanamandra K:
IL-10, IL-6 and CD14 polymorphisms and sepsis outcome in ventilated
very low birth weight infants. BMC Med. 4:102006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Prabhu Anand S, Selvaraj P, Jawahar MS,
Adhilakshmi AR and Narayanan PR: Interleukin-12B &
interleukin-10 gene polymorphisms in pulmonary tuberculosis. Indian
J Med Res. 126:135–138. 2007.
|
|
28
|
Ito M, Takahashi H, Fuse K, Hirono S,
Washizuka T, Kato K, Yamazaki F, Inano K, Furukawa T, Komada M and
Aizawa Y: Polymorphisms of tumor necrosis factor-alpha and
interleukin-10 genes in Japanese patients with idiopathic dilated
cardiomyopathy. Jpn Heart J. 41:183–191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Monraats PS, Pires NM, Agema WR,
Zwinderman AH, Schepers A, de Maat MP, Doevendans PA, de Winter RJ,
Tio RA, Waltenberger J, et al: Genetic inflammatory factors predict
restenosis after percutaneous coronary interventions. Circulation.
112:2417–2425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Monraats PS, Pires NM, Schepers A, Agema
WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans
PA, de Winter RJ, et al: Tumor necrosis factor-alpha plays an
important role in restenosis development. FASEB J. 19:1998–2004.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Donger C, Georges JL, Nicaud V, Morrison
C, Evans A, Kee F, Arveiler D, Tiret L and Cambien F: New
polymorphisms in the interleukin-10 gene--relationships to
myocardial infarction. Eur J Clin Invest. 31:9–14. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Karaca E, Kayık¸ıoğlu M, Onay H, Gündüz C
and Ozkınay F: The effect of interleukin-10 gene promoter
polymorphisms on early-onset coronary artery disease. Anadolu
Kardiyol Derg. 11:285–289. 2011.PubMed/NCBI
|
|
33
|
Koch W, Kastrati A, Böttiger C, Mehilli J,
von BN and Schömig A: Interleukin-10 and tumor necrosis factor gene
polymorphisms and risk of coronary artery disease and myocardial
infarction. Atherosclerosis. 159:137–144. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
McGlinchey PG, Spence MS, Patterson CC,
Allen AR, Murphy G, Savage DA, Maxwell AP and McKeown PP: Cytokine
gene polymorphisms in ischaemic heart disease: investigation using
family-based tests of association. J Mol Med (Berl). 82:756–761.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Nei M and Saitou N: Genetic relationship
of human populations and ethnic differences in reaction to drugs
and food. Prog Clin Biol Res. 214:21–37. 1986.PubMed/NCBI
|
